// App-Quantinova.ai

1268-323 : IS LIGHT TRANSMITTANCE AGGREGOMETRY STILL A USEFUL TOOL TO ASSESS PHARMACODYNAMIC EFFECTS OF ANTIPLATELET THERAPY?

Researchers

Presenter

  • Paul A. Gurbel

Principal Investigators

  • Martin Gesheff

  • Christopher Franzese

  • Kevin Bliden

  • Udaya Tantry

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Stable coronary artery disease

  • Coronary Artery Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved